We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMGWP
RNS Number : 2213N
GW Pharmaceuticals PLC
21 October 2016
GW Pharmaceuticals plc
Posting of Shareholder Circular
London, UK, 21 October 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, confirms that further to the announcement made on 19 October, a circular has been published and has been posted to shareholders in relation to the Company's intention to cancel the admission of its 0.1 pence ordinary shares to trading on AIM on 5 December, 2016.
A copy of the Circular is available on the Company's website at the following URL: http://www.gwpharm.com.
Enquiries:
GW Pharmaceuticals plc Stephen Schultz, VP Investor 917 280 2424 / 401 500 Relations (U.S.) 6570 FTI Consulting (Media Enquiries) Ben Atwell / Simon Conway +44 20 3727 1000 Peel Hunt LLP (UK NOMAD) James Steel +44 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
CIREASEFADDKFFF
(END) Dow Jones Newswires
October 21, 2016 11:37 ET (15:37 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
